Cited by 1,140Cancer, Hypoxia, and MetabolismDNA Repair MechanismsCell death mechanisms and regulation

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Hypoxia, DNA repair and genetic instability

Bristow, Robert G., Hill, Richard P.·2008·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Areas of hypoxic tumour tissue are known to be resistant to treatment and are associated with a poor clinical prognosis. There are several reasons why this might be, including the capacity of hypoxia to drive genomic instability and alter DNA damage repair pathways. Significantly, current models fail to distinguish between the complexities of the hypoxic microenvironment and the biological effects of acute hypoxia exposures versus longer-term, chronic hypoxia exposures on the transcription and translation of proteins involved in genetic stability and cell survival. Acute and chronic hypoxia might lead to different biology within the tumour and this might have a direct effect on the design of new therapies for the treatment of hypoxic tumours.

Integrity signals

Registry

Crossref · 10.1038/nrc2344

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Regulation of hypoxia-inducible factor 1α is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“When tissue metabolism exceeds metabolic supply, as is the case for most tumours, the hypoxic response leads to a series of changes in protein expression to protect against cell deat”
Background

Flagged first, then by citations

Show all 112 references

Sorted by citations

The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3007 · Cited by 1,155
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Molecular Basis of Metastasis
Chiang, A. C., & Massagué, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0805239 · Cited by 1,077
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 1,056
Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement
Goodarzi, H., Liu, X., Nguyen, H. C. B., Zhang, S., Fish, L., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2015.02.053 · Cited by 949
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 842
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
“Furthermore, hypoxia downregulates DNA repair gene expression, and hypoxia/reoxygenation cycles can induce DNA strand breaks and oxidative base damage, gene amplifications, and DNA over-replication (Bristow & Hill, 2008).”
Background
Molecular landmarks of tumor hypoxia across cancer types
Bhandari, V., Hoey, C., Liu, L. Y., Lalonde, E., Ray, J., Livingstone, J., Lesurf, R., Shiah, Y.-J., Vujcic, T., Huang, X., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0318-2 · Cited by 678
Self-citation
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3298 · Cited by 691
Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy
Chithrani, D. B., Jelveh, S., Jalali, F., van Prooijen, M., Allen, C. J., Bristow, R. G., Hill, R. P., & Jaffray, D. A. (2010) · Radiation Research · doi:10.1667/rr1984.1 · Cited by 682
Self-citation
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Graham, K., & Unger, E. C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s140462 · Cited by 594
Hypoxia-targeted drug delivery
Sharma, A. K., Arambula, J. F., Koo, S., Kumar, R., Singh, H., Sessler, J. L., & Kim, J. S. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00304a · Cited by 556
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
Wang, D., Wu, H., Phua, S. Z. F., Yang, G., Lim, W. Q., Gu, L., Qian, C., Wang, H., Guo, Z. G., Chen, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14199-7 · Cited by 545
TGF-β – an excellent servant but a bad master
Kubiczkova, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-183 · Cited by 511
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
Chao, Y., Xu, L., Liang, C., Feng, L., Xu, J., Dong, Z., Tian, L., Yi, X., Yang, K., & Liu, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0262-6 · Cited by 493
Role of hypoxia in the hallmarks of human cancer
Ruan, K., Song, G., & Ouyang, G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22214 · Cited by 493
Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression
Chen, Z., Li, Y., Zhang, H., Huang, P., & Luthra, R. (2010) · Oncogene · doi:10.1038/onc.2010.193 · Cited by 426
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 449
Targeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 431
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
Guillaumond, F., Leca, J., Olivares, O., Lavaut, M.-N., Vidal, N., Berthezène, P., Dusetti, N. J., Loncle, C., Calvo, E., Turrini, O., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219555110 · Cited by 413
EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
Chang, C. J., Yang, J.-Y., Xia, W., Chen, C.-T., Xie, X., Chao, C.-H., Woodward, W. A., Hsu, J.-M., Hortobágyi, G. N., & Hung, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.035 · Cited by 423
Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited
Pajonk, F., Vlashi, E., & McBride, W. H. (2010) · Stem Cells · doi:10.1002/stem.318 · Cited by 418
A Mesoporous Nanoenzyme Derived from Metal–Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy
Wang, D., Wu, H., Lim, W. Q., Phua, S. Z. F., Xu, P., Chen, Q., Guo, Z. G., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201901893 · Cited by 386
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Moustafa, A. A., & Malki, M. I. (2020) · Cancers · doi:10.3390/cancers12041050 · Cited by 410
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Lalonde, E., Ishkanian, A. S., Sykes, J., Fraser, M., Ross-Adams, H., Erho, N., Dunning, M. J., Halim, S., Lamb, A. D., Moon, N. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71021-6 · Cited by 342
Self-citation
Imaging tumour hypoxia with positron emission tomography
Fleming, I. N., Manavaki, R., Blower, P. J., West, C., Williams, K. J., Harris, A. L., Domarkas, J., Lord, S., Baldry, C., & Gilbert, F. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.610 · Cited by 332
Enhanced Chemodynamic Therapy by Cu–Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction
Koo, S., Park, O. K., Kim, J., Han, S. I., Yoo, T. Y., Lee, N., Kim, Y. G., Kim, H., Lim, C., Bae, J., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09171 · Cited by 316
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
Ali, H. R., Jackson, H. W., Zanotelli, V. R., Danenberg, E., Fischer, J. R., Bardwell, H. A., Provenzano, E., CRUK IMAXT Grand Challenge Team, Ali, H. R., Sa’d, M. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0026-6 · Cited by 313
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Yu, L., Yan, L., & Wang, H. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 309
Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem
Salas, Y. J., Márquez, A. A., Díaz, D., & Romero, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127381 · Cited by 282
Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
Milosevic, M., Warde, P. R., Ménard, C. M., Chung, P. W. M., Toi, A., Ishkanian, A., McLean, M., Pintilie, M., Sykes, J. R., Gospodarowicz, M. K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2711 · Cited by 282
Self-citation
Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
Hua, F., & DeClerck, Y. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0661 · Cited by 286
Advances in Application of Azobenzene as a Trigger in Biomedicine: Molecular Design and Spontaneous Assembly
Cheng, H., Zhang, S., Qi, J., Liang, X., & Yoon, J. (2021) · Advanced Materials · doi:10.1002/adma.202007290 · Cited by 286
Carbon Ion Radiobiology
Tinganelli, W., & Durante, M. (2020) · Cancers · doi:10.3390/cancers12103022 · Cited by 279
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy
Hughes, J. R., & Parsons, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186492 · Cited by 270
Molecular Pathways: Targeting ATR in Cancer Therapy
Karnitz, L. M., & Zou, L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0479 · Cited by 277
mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 264
Exosome-orchestrated hypoxic tumor microenvironment
Meng, W., Hao, Y., He, C., Li, L., & Zhu, G. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0982-6 · Cited by 256
Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
Kaluz, Š., Kaluzová, M., Liao, S., Lerman, M. I., & Stanbridge, E. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.01.001 · Cited by 262
Reactive oxygen species and cancer: A complex interaction
Saikolappan, S., Kumar, B., Shishodia, G., Koul, S., & Koul, H. K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.020 · Cited by 253
Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
Chan, N. H. L., Pires, I. M., Bencokova, Z., Coackley, C. L., Luoto, K. R., Bhogal, N., Lakshman, M., Gottipati, P., Oliver, F. J., Helleday, T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2352 · Cited by 250
Self-citation
From Low to No O 2 -Dependent Hypoxia Photodynamic Therapy (hPDT): A New Perspective
Li, M., Xu, Y., Peng, X., & Kim, J. S. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00531 · Cited by 246
Applying Synthetic Lethality for the Selective Targeting of Cancer
McLornan, D. P., List, A. F., & Mufti, G. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1407390 · Cited by 246
Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
Squatrito, M., Brennan, C., Helmy, K. Y., Huse, J. T., Petrini, J. H. J., & Holland, E. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.034 · Cited by 242
Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
Rodak, O., Peris‐Díaz, M. D., Olbromski, M., Podhorska‐Okołów, M., & Dzięgiel, P. (2021) · Cancers · doi:10.3390/cancers13184705 · Cited by 250
Redox Regulation of T-Cell Function: From Molecular Mechanisms to Significance in Human Health and Disease
Kesarwani, P., Murali, A. K., Al-Khami, A. A., & Mehrotra, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4073 · Cited by 242
Targeting the ATR-CHK1 Axis in Cancer Therapy
Rundle, S., Bradbury, A., Drew, Y., & Curtin, N. J. (2017) · Cancers · doi:10.3390/cancers9050041 · Cited by 242
Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force
Polet, F., & Féron, O. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12016 · Cited by 232
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 239
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Dewhirst, M. W. (2009) · Radiation Research · doi:10.1667/rr1926.1 · Cited by 228
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids
Riffle, S., & Hegde, R. S. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0570-9 · Cited by 231
Regulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 238
Tumor cell migration in complex microenvironments
Polacheck, W. J., Zervantonakis, I. K., & Kamm, R. D. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1115-1 · Cited by 229
Tumor hypoxia as a driving force in genetic instability
Luoto, K. R., Kumareswaran, R., & Bristow, R. G. (2013) · Genome Integrity · doi:10.1186/2041-9414-4-5 · Cited by 234
Self-citation
Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
Hayashi, Y., Yokota, A., Harada, H., & Huang, G. (2019) · Cancer Science · doi:10.1111/cas.13990 · Cited by 229
The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
Hammond, E. M., Asselin, M., Forster, D. M., O’Connor, J. P. B., Senra, J. M., & Williams, K. J. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.02.002 · Cited by 227
Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression
Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 223
Design of Hybrid MnO2‐Polymer‐Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment
Gordijo, C. R., Abbasi, A. Z., Amini, M. A., Lip, H. Y., Maeda, A., Cai, P., O'Brien, P. J., DaCosta, R. S., Rauth, A. M., & Wu, X. Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404511 · Cited by 211
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Daniel, S. K., Sullivan, K. M., Labadie, K. P., & Pillarisetty, V. G. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0226-9 · Cited by 215
Exosomes in development, metastasis and drug resistance of breast cancer
Yu, D., Wu, Y., Shen, H., Lv, M., Chen, W., Zhang, X., Zhong, S., Tang, J., & Zhao, J. (2015) · Cancer Science · doi:10.1111/cas.12715 · Cited by 208
Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
Achyut, B. R., & Yang, H. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 203
Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair
Davis, L., & Maizels, N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400236111 · Cited by 212
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Ge, R., Wang, Z., & Liang Cheng, C. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00272-w · Cited by 212
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects
Takes, R. P., Rinaldo, A., Silver, C. E., Haigentz, M., Woolgar, J. A., Triantafyllou, A. G., Mondin, V., Paccagnella, D., de Bree, R., Shaha, A. R., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.03.013 · Cited by 199
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Telarović, I., Wenger, R. H., & Pruschy, M. N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02000-x · Cited by 208
Aggregation‐Induced Emission Gold Clustoluminogens for Enhanced Low‐Dose X‐ray‐Induced Photodynamic Therapy
Sun, W., Luo, L., Feng, Y., Cai, Y., Zhuang, Y., Xie, R., Chen, X. S., & Chen, H. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908712 · Cited by 186
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
Corbin, K. S., Hellmän, S., & Weichselbaum, R. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9651 · Cited by 185
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Harada, H., Inoue, M., Itasaka, S., Hirota, K., Morinibu, A., Shinomiya, K., Zeng, L., Ou, G., Zhu, Y., Yoshimura, M., et al. (2012) · Nature Communications · doi:10.1038/ncomms1786 · Cited by 183
Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities
Beckers, C., Pruschy, M. N., & Vetrugno, I. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.006 · Cited by 198
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Ward, C., Langdon, S. P., Mullen, P., Harris, A. L., Harrison, D. J., Supuran, C. T., & Kunkler, I. H. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.004 · Cited by 185
The impact of tumour pH on cancer progression: strategies for clinical intervention
Ward, C., Meehan, J., Gray, M., Murray, A. F., Argyle, D. J., Kunkler, I. H., & Langdon, S. P. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00005 · Cited by 180
Tumor acidity: From hallmark of cancer to target of treatment
Bogdanov, A. A., Bogdanov, A., Chubenko, V. A., Volkov, N., Moiseenko, F. V., & Moiseyenko, V. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.979154 · Cited by 187
Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu
Rattigan, Y. I., Hsu, J., Mishra, P. J., Glod, J. W., & Banerjee, D. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.07.002 · Cited by 183
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Rapisarda, A., & Melillo, G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.64 · Cited by 178
Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma
Liu, Z., Wang, Y., Dou, C., Xu, M. M., Sun, L., Wang, L., Yao, B., Li, Q., Yang, W., Tu, K., et al. (2018) · Theranostics · doi:10.7150/thno.26789 · Cited by 172
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer HeterogeneityPreprint
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 179
Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
Pires, I. M., Olcina, M. M., Anbalagan, S., Pollard, J. R., Reaper, P. M., Charlton, P., McKenna, W. G., & Hammond, E. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.265 · Cited by 175
Hypoxia and hypoxia inducible factors in tumor metabolism
Zeng, W., Liu, P., Pan, W., Singh, S. R., & Wei, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.032 · Cited by 174
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas
Bártková, J., Hamerlik, P., Stockhausen, M.-T., Ehrmann, J., Hlobílková, A., Laursen, H. B., Kalita, O., Kolář, Z., Poulsen, H. S., Broholm, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.249 · Cited by 174
Modulation of the tumor vasculature and oxygenation to improve therapy
Siemann, D. W., & Horsman, M. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.006 · Cited by 169
Hypoxia‐mediated biological control
Cassavaugh, J. M., & Lounsbury, K. M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22956 · Cited by 177
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
Li, Y., Zhao, L., & Li, X.-F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700407 · Cited by 172
APE1/Ref-1Role in Redox Signaling: Translational Applications of Targeting the Redox Function of the DNA Repair/Redox Protein APE1/Ref-1
Kelley, M. R., Georgiadis, M. M., & Fishel, M. L. (2011) · Current Molecular Pharmacology · doi:10.2174/1874467211205010036 · Cited by 168
Patient Blood Management
Spahn, D. R., Moch, H., Hofmann, A., & Isbister, J. P. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31818e3d75 · Cited by 165
Glycolytic enzyme inhibitors in cancer treatment
Scatena, R., Bottoni, P., Pontoglio, A., Mastrototaro, L., & Giardina, B. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1533 · Cited by 167
Kill-painting of hypoxic tumours in charged particle therapy
Tinganelli, W., Durante, M., Hirayama, R., Krämer, M., Maier, A., Kraft-Weyrather, W., Furusawa, Y., Friedrich, T., & Scifoni, E. (2015) · Scientific Reports · doi:10.1038/srep17016 · Cited by 164
Understanding the central role of citrate in the metabolism of cancer cells
Icard, P., Poulain, L., & Lincet, H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.007 · Cited by 167
Molecular mechanisms of hypoxia in cancer
Challapalli, A., Carroll, L. S., & Aboagye, E. O. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0231-1 · Cited by 167
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial
Riaz, N., Sherman, E. J., Pei, X., Schöder, H. M., Grkovski, M., Paudyal, R., Katabi, N., Selenica, P., Yamaguchi, T. N., Ma, D. J., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa184 · Cited by 161

Authors: Bristow, R. G., & Hill, R. P.
Affiliations: University Health Network (CA)
Corresponding author: Bristow, Robert G.
ORCID: Bristow, Robert G.
Hill, Richard P.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 8
Issue: 3
Pages: 180-192
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2344
OpenAlex: W2012276721
Cited by: 1,140
References: 112
Citations by year: 2026: 29 · 2025: 60 · 2024: 44 · 2023: 51 · 2022: 75 · 2021: 86 · 2020: 70 · 2019: 70 · 2018: 78 · 2017: 66 · 2016: 54 · 2015: 50 · 2014: 63 · 2013: 66 · 2012: 73
FWCI: 4.89
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Cancer Institute
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: chronic hypoxia, acute hypoxia, genomic instability, DNA repair, treatment resistance, cancer prognosis, cancer therapy design
MeSH terms: Animals, Hypoxia, DNA Damage, DNA Repair, Humans, Models, Biological, Neoplasm Metastasis, Neoplasms, Phenotype, Transcription, Genetic, Protein Biosynthesis, Gene Expression Regulation, Neoplastic, Disease Progression, Genomic Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia, DNA repair and genetic instability

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks